Cargando…
The progesterone receptor Val660→Leu polymorphism and breast cancer risk
BACKGROUND: Recent evidence suggests a role for progesterone in breast cancer development and tumorigenesis. Progesterone exerts its effect on target cells by interacting with its receptor; thus, genetic variations, which might cause alterations in the biological function in the progesterone recepto...
Autores principales: | De Vivo, Immaculata, Hankinson, Susan E, Colditz, Graham A, Hunter, David J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064075/ https://www.ncbi.nlm.nih.gov/pubmed/15535845 http://dx.doi.org/10.1186/bcr928 |
Ejemplares similares
-
Polymorphic repeat in AIB1 does not alter breast cancer risk
por: Haiman, Christopher A, et al.
Publicado: (2000) -
Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study
por: Okobia, Michael N, et al.
Publicado: (2009) -
No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population.
por: Cho, Ki-Hyun, et al.
Publicado: (2002) -
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study
por: Rosner, Bernard, et al.
Publicado: (2008) -
Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case–control study
por: Tamimi, Rulla M, et al.
Publicado: (2004)